These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4842910)

  • 21. The effect of poly (aspartic acid-co-lactic acid) nanospheres on the lung metastasis of B16BL6 melanoma cells by intravenous administration.
    Hara K; Tsujimoto H; Huang CC; Kawashima Y; Mimura H; Miwa N
    Oncol Rep; 2006 Dec; 16(6):1215-20. PubMed ID: 17089040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

  • 23. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
    Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
    J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of pulmonary metastasis by Nocardia rubra cell wall skeleton, with special reference to macrophage activation.
    Kagawa K; Yamashita T; Tsubura E; Yamamura Y
    Cancer Res; 1984 Feb; 44(2):665-70. PubMed ID: 6692370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tum- variants and the detection of tumor-specific transplantation antigens on spontaneous mouse tumors.
    Boon T; van Pel A; Uyttenhove C; Marchand M; Lambotte P
    Behring Inst Mitt; 1984 May; (74):209-13. PubMed ID: 6332616
    [No Abstract]   [Full Text] [Related]  

  • 26. Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.
    Abdel-Wahab Z; Dar M; Osanto S; Fong T; Vervaert CE; Hester D; Jolly D; Seigler HF
    Cancer Gene Ther; 1997; 4(1):33-41. PubMed ID: 9012449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes.
    Gautam A; Densmore CL; Waldrep JC
    Mol Ther; 2000 Oct; 2(4):318-23. PubMed ID: 11020346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the spleen in active and adoptive immunization.
    Stein-Werblowsky R
    J Reticuloendothel Soc; 1974 May; 15(5):361-70. PubMed ID: 4855070
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of immunological and anti-tumour effects of orally administered Corynebacterium papvum in mice.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Mar; 31(3):359-63. PubMed ID: 1156520
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucan immunotherapy as adjunct in the surgical excision of experimental melanoma.
    Browder W; McNamee R; Di Luzio N
    Surg Forum; 1977; 28():171-3. PubMed ID: 617407
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of anti-transplantation immunity of tumor.
    Ito T
    Acta Pathol Jpn; 1968 May; 18(2):207-25. PubMed ID: 5755103
    [No Abstract]   [Full Text] [Related]  

  • 33. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ; Schroit AJ
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of BCG on B16 mouse melanoma: a comparison of routes of administration on tumour growth at different anatomical sites.
    Proctor JW; Auclair BG; Lewis MG
    Eur J Cancer (1965); 1976 Mar; 12(3):203-10. PubMed ID: 939237
    [No Abstract]   [Full Text] [Related]  

  • 35. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16].
    Gankovskaia LV; Pyl'nova TI; Sokolova EV; Koval'chuk LV
    Biull Eksp Biol Med; 1980 Sep; 90(9):346-8. PubMed ID: 7000202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease.
    Poste G; Kirsh R
    Prog Clin Biol Res; 1982; 102 pt A():309-19. PubMed ID: 7167443
    [No Abstract]   [Full Text] [Related]  

  • 38. A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo.
    Umansky V; Beckhove P; Rocha M; Krüger A; Crocker PR; Schirrmacher V
    Immunology; 1996 Feb; 87(2):303-9. PubMed ID: 8698395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA extracts in tumor immunity. Induction of anti-cancer immunity with RNA.
    Pilch YH; Ramming KP; Deckers PJ
    Ann N Y Acad Sci; 1973 May; 207():409-29. PubMed ID: 4517718
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    J Natl Cancer Inst; 1973 Aug; 51(2):637-44. PubMed ID: 4765377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.